Clinical trial registry record

Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated April 1, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03761706
Last registry update
April 1, 2025
Status
Completed
Phase
Phase not reported
Sponsor
UNC Lineberger Comprehensive Cancer Center
Enrollment
132
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NA · SINGLE GROUP · PREVENTION · NONE
Evidence population
Human clinical study registration
Participants
132
Population
FEMALE · 21 Years to 99 Years
Duration
2018-02-28 to 2025-02-01
Intervention
Engagement in Physical Activity; Questionnaires
Comparator
Not reported
Outcomes measured
Compare the change in p16 from baseline to end of chemotherapy — Baseline, 6-months post Baseline, 12-months post-Basel…; Measure association of physical activity levels (Fitbit steps and strength training) with change in p16 levels — Baseli…; Measure associations between weight, physical activity and diet during chemotherapy. — Baseline, 3-months post-Baseline…; Chemotherapy-induced peripheral neuropathy (CIPN) as assessed by the FACT/GOG-NTX — Baseline, During Chemotherapy (from…; Chemotherapy-induced peripheral neuropathy (CIPN) as assessed by the CTCAE. — Baseline, During Chemotherapy (from 1st i…; Chemotherapy-induced peripheral neuropathy (CIPN) as assessed by the PRO-CTCAE. — Baseline, During Chemotherapy (from 1…; Chemotherapy-induced peripheral neuropathy (CIPN) as assessed by the SPPB. — Baseline, During Chemotherapy (from 1st in…; Measure association of p16 with changes in QOL measures as assessed by the FACT-G — Baseline, 6-months post-Baseline, 1…; Measure association of p16 with changes in QOL measures as assessed by the FACIT-F — Baseline, 6-months post-Baseline,…; Measure association of p16 with changes in QOL measures as assessed by the MHI-17 — Baseline, 6-months post-Baseline, 1…; Measure association of p16 with changes in QOL measures as assessed by the MOS Social Activity Limitation Questionnaire…; Measure association of p16 with changes in QOL measures as assessed by the PROMIS Instrumental Support — Baseline, 6-mo…; Measure association of p16 with changes in QOL measures as assessed by the PROMIS Social Isolation Questionnaire. — Bas…; Measure association of p16 with changes in QOL measures as assessed by the PROMIS Global Health — Baseline, 6-months po…; Measure association of p16 with changes in cognition by the PROMIS Cognitive Function-Short Form — Baseline, 6-months p…; Measure association of p16 with changes in cognition by the Blessed Memory Concentration test (BOMC) — Baseline, 6-mont…; Measure association of p16 with changes in functional status by the Timed Up and Go Test — Baseline, 6-months post-Base…; Measure association of p16 with changes in functional status by the Medical Outcomes Survey. — Baseline, 6-months post-…; Measure association of p16 with changes in functional status with the Instrumental Activities of Daily Living Survey —…; Measure association of p16 with changes in functional status with the Karnofsky Performance Status — Baseline, 6-months…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
  • Exercise · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.